IRIS UniCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.967
NA - Nord America 1.735
AS - Asia 1.001
SA - Sud America 315
AF - Africa 29
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.702
DE - Germania 563
SE - Svezia 382
SG - Singapore 358
CN - Cina 314
IT - Italia 310
BR - Brasile 293
FR - Francia 126
IE - Irlanda 123
UA - Ucraina 111
GB - Regno Unito 100
ID - Indonesia 78
FI - Finlandia 69
IN - India 66
RU - Federazione Russa 66
TR - Turchia 31
BD - Bangladesh 26
BE - Belgio 26
KR - Corea 25
VN - Vietnam 20
PL - Polonia 17
CA - Canada 16
HK - Hong Kong 15
AT - Austria 11
ZA - Sudafrica 11
IQ - Iraq 10
NL - Olanda 10
AR - Argentina 9
JP - Giappone 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
IR - Iran 7
LT - Lituania 7
ES - Italia 6
GR - Grecia 6
PE - Perù 6
PK - Pakistan 6
RO - Romania 6
CH - Svizzera 5
CI - Costa d'Avorio 5
DK - Danimarca 5
JM - Giamaica 5
AU - Australia 4
DZ - Algeria 4
EU - Europa 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IL - Israele 3
UZ - Uzbekistan 3
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
MA - Marocco 2
MX - Messico 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
RE - Reunion 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PW - Palau 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.057
Salva come PNG Salva come JPEG
Città #
Chandler 322
Singapore 246
Ashburn 159
Dublin 123
New York 76
Rome 76
Jakarta 75
Milan 68
Jacksonville 62
San Mateo 51
Nanjing 49
Hefei 47
Munich 46
Wilmington 46
Cattolica 41
Chicago 41
Los Angeles 41
Boston 38
Helsinki 38
Dearborn 35
Moscow 34
Marseille 31
Princeton 28
Frankfurt am Main 27
The Dalles 27
Brussels 26
Seoul 25
Ann Arbor 22
Beijing 22
São Paulo 21
Nürnberg 19
Woodbridge 19
Redwood City 17
Saint Petersburg 17
Nuremberg 16
Augusta 15
Izmir 15
London 15
Nanchang 15
Bremen 14
Falls Church 13
Seattle 13
Hong Kong 12
Turku 12
Changsha 11
Hanoi 11
Tianjin 11
Atlanta 10
Boardman 10
Hebei 10
Kraków 10
Norwalk 10
Santa Clara 10
Shenyang 10
Bexley 9
Fairfield 9
Falkenstein 8
Houston 8
Istanbul 8
Kunming 8
Lauterbourg 8
Lawrence 8
Rio de Janeiro 8
Brasília 7
Dhaka 7
Düsseldorf 7
Goiânia 7
Guangzhou 7
North Bergen 7
Washington 7
Amsterdam 6
Brno 6
Guarulhos 6
Jiaxing 6
Lancaster 6
Leawood 6
Portland 6
Portsmouth 6
San Diego 6
Abidjan 5
Athens 5
Baghdad 5
Belo Horizonte 5
Fremont 5
Lima 5
Palermo 5
San Jose 5
Toronto 5
Zhengzhou 5
Campinas 4
Curitiba 4
Edinburgh 4
Ho Chi Minh City 4
Jinan 4
Johannesburg 4
Manaus 4
Manchester 4
Mountain View 4
Mumbai 4
Ottawa 4
Totale 2.529
Salva come PNG Salva come JPEG
Nome #
A phase II study of sunitinib in advanced hepatocellular carcinoma 219
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 198
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 175
Vanishing-recurrent benign liver lesions 134
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 131
[The treatment of hepatocellular carcinoma: an update] 125
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 118
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 114
Liver transplantation in patients with alcoholic liver disease: A retrospective study 114
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 113
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 105
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 104
Severe giant cell arteritis associated with essential thrombocythaemia. 103
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 103
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 102
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 93
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 92
A giant calcified hepatic mass 91
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 88
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 86
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 84
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 83
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 83
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 79
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 76
Acute HEV hepatitis: clinical and laboratory diagnosis 73
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 71
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 69
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 69
Fatty liver and drugs: the two sides of the same coin 69
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 64
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 63
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 62
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 61
Liver transplantation for drug-induced acute liver failure 60
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 58
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 58
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 57
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 56
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 54
Clinical impact of comorbidities in an Italian NAFLD cohort 54
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 53
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 52
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 51
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 51
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 49
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 48
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 46
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 46
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 45
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 45
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 45
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 44
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 44
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 44
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 44
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 43
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 43
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 42
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 42
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 41
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 41
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 40
Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study 36
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 35
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 34
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 33
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 32
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 29
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 27
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 26
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 25
Upper limits of downstaging for hepatocellular carcinoma in liver transplantation 21
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 16
Abdominal angina 15
Totale 5.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021245 4 25 10 35 38 10 25 9 33 13 36 7
2021/2022406 14 23 9 49 36 16 15 69 14 17 65 79
2022/20231.070 132 110 55 144 93 157 63 94 103 33 69 17
2023/2024708 48 171 26 46 34 109 45 33 13 40 47 96
2024/20251.415 31 29 125 55 107 54 42 61 204 131 310 266
2025/2026286 286 0 0 0 0 0 0 0 0 0 0 0
Totale 5.139